COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CHCT • US20369C1062

17.55 USD
+0.16 (+0.92%)
At close: Feb 3, 2026
17.43 USD
-0.12 (-0.68%)
After Hours: 2/3/2026, 8:05:48 PM
Fundamental Rating

3

Overall CHCT gets a fundamental rating of 3 out of 10. We evaluated CHCT against 124 industry peers in the Diversified REITs industry. CHCT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CHCT is valued expensive at the moment. CHCT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CHCT had negative earnings in the past year.
  • In the past year CHCT had a positive cash flow from operations.
  • CHCT had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years CHCT had a positive operating cash flow.
CHCT Yearly Net Income VS EBIT VS OCF VS FCFCHCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.06%, CHCT is doing worse than 67.74% of the companies in the same industry.
  • CHCT's Return On Equity of -2.46% is on the low side compared to the rest of the industry. CHCT is outperformed by 66.94% of its industry peers.
  • CHCT has a Return On Invested Capital of 2.27%. This is comparable to the rest of the industry: CHCT outperforms 42.74% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHCT is in line with the industry average of 3.05%.
Industry RankSector Rank
ROA -1.06%
ROE -2.46%
ROIC 2.27%
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
CHCT Yearly ROA, ROE, ROICCHCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3 4

1.3 Margins

  • The Operating Margin of CHCT (23.26%) is comparable to the rest of the industry.
  • CHCT's Operating Margin has declined in the last couple of years.
  • CHCT has a better Gross Margin (80.68%) than 81.45% of its industry peers.
  • CHCT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.26%
PM (TTM) N/A
GM 80.68%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
CHCT Yearly Profit, Operating, Gross MarginsCHCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHCT is destroying value.
  • The number of shares outstanding for CHCT has been increased compared to 1 year ago.
  • Compared to 5 years ago, CHCT has more shares outstanding
  • The debt/assets ratio for CHCT is higher compared to a year ago.
CHCT Yearly Shares OutstandingCHCT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHCT Yearly Total Debt VS Total AssetsCHCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 0.84, we must say that CHCT is in the distress zone and has some risk of bankruptcy.
  • With a decent Altman-Z score value of 0.84, CHCT is doing good in the industry, outperforming 66.94% of the companies in the same industry.
  • CHCT has a Debt/Equity ratio of 1.25. This is a high value indicating a heavy dependency on external financing.
  • CHCT has a Debt to Equity ratio (1.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.33
WACC6.79%
CHCT Yearly LT Debt VS Equity VS FCFCHCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • CHCT has a Current Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CHCT's Current ratio of 0.47 is on the low side compared to the rest of the industry. CHCT is outperformed by 80.65% of its industry peers.
  • A Quick Ratio of 0.16 indicates that CHCT may have some problems paying its short term obligations.
  • CHCT's Quick ratio of 0.16 is on the low side compared to the rest of the industry. CHCT is outperformed by 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.16
CHCT Yearly Current Assets VS Current LiabilitesCHCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

  • CHCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -146.88%.
  • Measured over the past years, CHCT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.22% on average per year.
  • The Revenue for CHCT has decreased by -17.52% in the past year. This is quite bad
  • Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 13.73% on average per year.
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%

3.2 Future

  • Based on estimates for the next years, CHCT will show a very strong growth in Earnings Per Share. The EPS will grow by 42.04% on average per year.
  • The Revenue is expected to grow by 9.35% on average over the next years. This is quite good.
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue Next Year5.07%
Revenue Next 2Y5.72%
Revenue Next 3Y6.67%
Revenue Next 5Y9.35%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHCT Yearly Revenue VS EstimatesCHCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
CHCT Yearly EPS VS EstimatesCHCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CHCT. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 36.61, CHCT can be considered very expensive at the moment.
  • CHCT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHCT is cheaper than 70.16% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.51. CHCT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 36.61
CHCT Price Earnings VS Forward Price EarningsCHCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.44
CHCT Per share dataCHCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CHCT's earnings are expected to grow with 42.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.09%
EPS Next 3Y42.04%

More info and screens

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 11.14%, CHCT is a good candidate for dividend investing.
  • CHCT's Dividend Yield is rather good when compared to the industry average which is at 6.98. CHCT pays more dividend than 95.97% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, CHCT pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.14%

5.2 History

  • The dividend of CHCT has a limited annual growth rate of 2.99%.
  • CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
CHCT Yearly Dividends per shareCHCT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • CHCT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • CHCT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-507.68%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
CHCT Yearly Income VS Free CF VS DividendCHCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

More info and screens

COMMUNITY HEALTHCARE TRUST I

NYSE:CHCT (2/3/2026, 8:05:48 PM)

After market: 17.43 -0.12 (-0.68%)

17.55

+0.16 (+0.92%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-28
Earnings (Next)02-17
Inst Owners83.09%
Inst Owner Change-2.62%
Ins Owners5.89%
Ins Owner Change4.96%
Market Cap499.65M
Revenue(TTM)119.55M
Net Income(TTM)-10.49M
Analysts81.82
Price Target18.16 (3.48%)
Short Float %2.15%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield 11.14%
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-507.68%
Div Incr Years9
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.89%
Min EPS beat(2)-88.54%
Max EPS beat(2)-63.24%
EPS beat(4)0
Avg EPS beat(4)-63.43%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-53.34%
EPS beat(12)1
Avg EPS beat(12)-60.44%
EPS beat(16)1
Avg EPS beat(16)-48.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.34%
Revenue beat(12)1
Avg Revenue beat(12)-2.84%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)-6.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.13%
Revenue NQ rev (3m)1.76%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.61
P/S 4.18
P/FCF N/A
P/OCF 8.83
P/B 1.17
P/tB 1.17
EV/EBITDA 14.44
EPS(TTM)-0.15
EYN/A
EPS(NY)0.48
Fwd EY2.73%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)1.99
OCFY11.33%
SpS4.2
BVpS14.99
TBVpS14.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.06%
ROE -2.46%
ROCE 2.88%
ROIC 2.27%
ROICexc 2.28%
ROICexgc 2.32%
OM 23.26%
PM (TTM) N/A
GM 80.68%
FCFM N/A
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexgc growth 3Y-9.66%
ROICexgc growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA 7.48
Cap/Depr 145.76%
Cap/Sales 53.07%
Interest Coverage 1.1
Cash Conversion 79.35%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.16
Altman-Z 0.84
F-Score3
WACC6.79%
ROIC/WACC0.33
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
Revenue Next Year5.07%
Revenue Next 2Y5.72%
Revenue Next 3Y6.67%
Revenue Next 5Y9.35%
EBIT growth 1Y-32.49%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year265.38%
EBIT Next 3Y62.68%
EBIT Next 5YN/A
FCF growth 1Y92.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.45%
OCF growth 3Y1.48%
OCF growth 5Y12.72%

COMMUNITY HEALTHCARE TRUST I / CHCT FAQ

What is the fundamental rating for CHCT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHCT.


What is the valuation status for CHCT stock?

ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.


What is the profitability of CHCT stock?

COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 3 / 10.


Can you provide the financial health for CHCT stock?

The financial health rating of COMMUNITY HEALTHCARE TRUST I (CHCT) is 1 / 10.